WHAT THE MANUFACTURING LANDSCAPE CAN TELL US NOW
WEEKLY COVID VACCINE RESEARCH UPDATE Saturday, May 15, 2021 INSIGHTS What the manufacturing landscape can tell us now Author: Andrea Taylor Manufacturing projections for Covid-19 vaccines seem to shift on a near-weekly basis. We are not even halfway into 2021 and already we have seen adjustments, both up and down, across all vaccine makers. 2021 projections differ by vaccine platform Overall, we see 2021 projections increasing for mRNA vaccines Pfizer-BioNTech and Moderna, while decreasing for viral vector vaccines Oxford-AstraZeneca and Janssen (J&J). AstraZeneca, in particular, has faced significant manufacturing issues throughout its global production network. In addition to the well-covered constraints slowing down manufacturing in Europe and the Serum Institute of India, partners in Mexico, Brazil, and elsewhere have struggled to get production started or sustained. Janssen’s vaccine has also experienced setbacks, including the temporary…